Tron Logo
Trade on HitBTC
Like this video

Ratings GENEXI

Accelerating Biotech Breakthroughs

There are many challenges facing the biotech industry today, such as quality assurance, counterfeiting and research intransparency. GENEXI is determined to deliver a holistic solution in the form of a transparent and comprehensive blockchain-based ecosystem on to the market. Within GENEXI Ecosystem biotech start-ups and projects will be able to find financial and advisory support to establish and scale-up their production. Upon entering the GENEXI Platform, distributors will be able to provide their services and build networks with vendors, while regular customers will gain an access to complete immutable data about the products. At the same time, third-party service providers will be able to present their support to other participants of the community. GENEXI plans to integrate its unique blockchain solution throughout the entire supply chain management process in order to fight drug counterfeit, fraud and quality manipulation and ensure full transparency at every level.

4.3
9 8 expert ratings
Benchy 3.4
KYC
Experts
4.9
4.6
4.4
Review: coming soon PRO
~$37,000,000
value of tokens sold in ICO

Ended
Token
GEN Token
Type
Price in ICO
0.0100 USD
Country
Whitelist/KYC
KYC
Restricted areas
USA
preICO start
1st May 2018
preICO end
31st May 2018
ICO start
1st Jun 2018
ICO end
10th Sep 2018
Visit ICO website
Report

Ratings

All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Hung Chih (Jason Hung)
Cofounder of International Consensus Association | Investor Relation | China Market
Rated on May 19, 2018
5
5
4
11%

The project intend to build transparency ecosystem for biotech and encourage the participation by using token as a media. It's a good direction and I looking forward to see it works.

However, from my many years experience of doing business with biotech, the player in biotech industry is usually very conservation and self-protected.

So, I think the challenge is not technology but how to promote and convincing all player. The core team is strong, but I will recommend invite more channel and sales partner to speed up market adaption.

Good luck!

+1Agree
-1
-2Disagree
Report
Igor Karavaev
Blockchain Enthusiast and Advisor
Rated on Jul 4, 2018
Modified on Jul 4, 2018
5
4
5
11%

The biotech industry has a great perspective using blockchain. This team is reinforced and quite numerous. This is a project with a good potential if well implemented. The WP still should be a bit improved as comes to numbers.

+5Agree
-4
-9Disagree
Report
Brian Condenanza
CTO at Bidao - Stablecoin and DeFi on Binance Chain, Crypto Entrepreneur, TEDx Speaker
Rated on Sep 7, 2018
Modified on Sep 7, 2018
5
4
4
10%

Very interesting product, although this is a very hard ecosystem to break in, as biotech breakthroughs can be very expensive to get. Great team and advisory board. Good luck team!

Agree
-1
-1Disagree
Report
Nikolay Shkilev
PhD | Entrepreneur | CEO | ICO Advisor | Crypto enthusiast | Blockchain expert | Public speaker | Mentor
Rated on May 27, 2018
5
5
4
10%

UPD: Good and big team.
Great vision. And biotech is huge market.
MVP - will soon!
KYC - passed it's good
Vision is good
Need more strong marketing and PR

+3Agree
+1
-2Disagree
Report
James Sowers
Ico adviser
Rated on May 15, 2018
5
5
5
10%

Great concept a biotech accelerator providing a Blockchain based solution!

+2Agree
0
-2Disagree
Report
Vlad Skakun
Co-Founder and CFO at CryptoDiffer | Investor| Marketing Specialist| Senior Analyst at Venture Fund
Rated on May 21, 2018
5
5
5
8%

Nowadays biotech industry is very promising and implementation blockchain technology in it could provide a great competitive advantage to the project.

GENEXI wants to create not just some local solution but a complex product which will help to solve the problem of the supply chain, drug counterfeit, fraud and quality manipulation.

They have a solid and experienced team in the business sphere. Their MVP will be launched in Q3 this year, keep waiting.

+2Agree
0
-2Disagree
Report
Vladimir Manzyuk
Blockchain/System Analyst
Rated on May 24, 2018
5
5
5
8%

In my opinion:
- Good team
- Nice vision
- The fact that the company is registered in Switzerland is a big plus for investors
- The market has high CAGR

+1Agree
+1
Disagree
Report
Suraj Tiwari
ICO ADVISOR CONSULTING EXCHANGES Listing SMART CONTRACT TOKEN CODE
Rated on Jun 14, 2018
3
4
3
5%

Team : looks great but when checked linked most of them either dont have it or have few connections.

Vision is good but i think they have to work very hard for it.

Product : cant see any prototype though the website was awesome but cant rate a website.

+1Agree
0
-1Disagree
Report
Benchy
ICO analyzer bot
3.4
25%

Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.

Ratings and ICO analyzer results are being updated (re-calculated) every few hours.

Add to bookmarks
ICO KYC Report
2 members invited
Alexey Zhelyaskov
Passed
Alexey Kirillov
Passed
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

4.6

Mindsync

Mindsync is a platform to solve customer's tasks with AI technologies competitions as w...

15 days 11 hours left
4.6

HiveNet

HiveNet is a distributed cloud computing network, which enables computer owners to rent...

38 days 11 hours left
4.6

Max Crowdfund

Max Crowdfund is an International Real Estate Crowdfunding Platform and Property Manage...

61 days 1 hour left
4.4

GRAYLL

GRAYLL is a start & stop system containing algorithms & AI models to automatically gene...

12 days 11 hours left

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it